XML 23 R13.htm IDEA: XBRL DOCUMENT
v3.22.1

Accrued Expenses | 3 Months Ended
--- | ---
Mar. 31, 2022
Payables And Accruals [Abstract] |
Accrued Expenses |
6. | Accrued Expenses
Accrued expenses consisted of the following at March 31, 2022 and December 31, 2021 (in thousands):
|  | March 31, |  |  | December 31, |
|  | 2022 |  |  | 2021 |
Personnel costs |  | $ | 3,057 |  |  | $ | 7,321 |
Clinical trial costs |  |  | 2,016 |  |  |  | 753 |
Professional fees |  |  | 482 |  |  |  | 712 |
Sales chargebacks, rebates and other revenue reserves |  |  | 4,054 |  |  |  | 2,974 |
Commissions due to DEXYCU commercial partner |  |  | 1,573 |  |  |  | 1,518 |
Other |  |  | 1,147 |  |  |  | 1,144 |
|  | $ | 12,329 |  |  | $ | 14,422 |

X
- Definition The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.19(a),20,24) -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682 + Details
Name: | us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_PayablesAndAccrualsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration